{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-040230","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2025-03-17T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.094755+00:00","generated_at":"2026-05-24T15:13:21.957898+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Enanta stockholders approve 800k-share increase to 2019 equity plan; re-elect directors","bullets":["Stockholders approved amendment to 2019 Equity Incentive Plan, adding 800,000 shares (11,435,985 for, 4,085,303 against).","Mark G. Foletta and Lesley Russell re-elected as Class III directors until 2028 annual meeting.","Advisory vote on executive compensation passed (14,516,861 for, 1,039,888 against); frequency set to annual.","PricewaterhouseCoopers LLP ratified as independent auditor for fiscal 2025 (17,740,127 for, 72,357 against)."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-040230","json":"https://secwatch.observer/filing/0000950170-25-040230.json","markdown":"https://secwatch.observer/filing/0000950170-25-040230.md","text":"https://secwatch.observer/filing/0000950170-25-040230.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000095017025040230/0000950170-25-040230-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000095017025040230/enta-20250313.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T15:13:21.957898+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}